Home


Home

Exhibitors Crowd at 2019 U.S.C.A.

Hyatt Regency New Orleans, September 12-15, 2024

Dafina Ward, JD

Dafina Ward, JD

Join us in New Orleans, LA where the 2024 United States Conference on HIV/AIDS (USCHA) will focus on HIV in the South. This year’s theme is #SouthernJoy. NMAC is convening a Southern Advisory Committee to highlight the challenges and resiliency surrounding HIV in Southern States.

Dafina Ward, JD, the executive director of the Southern AIDS Coalition will serve as chair of the Advisory Committee.  This year’s meeting will center the stories of those living with and impacted by HIV in the region, celebrate the transformative work happening across southern communities, and tell stories of overcoming adversity while fighting systemic racism and numerous factors that drive disparities and injustice.

The program will feature over 180 institutes, workshops and 30 poster presentations on prevention, biomedical tools, advocacy, and treatment and research. Be there to engage in impactful discussions, network and collaborate with experts in the field. Make sure to visit the Abstracts tab to submit a session proposal.

USCHA is the place to reach a diversity of participants as it brings together thousands of front-line responders leading the domestic response to HIV and AIDS – including consumers, case managers, health care and public health professionals, concerned advocates, and private sector partners.  Conference sponsorship allows organizations a tailored presence with a range of benefits including priority placement in the exhibit hall.  Exhibit hall space is limited and usually sells out before the deadline, reserve your booth now to secure your spot. Visit our Exhibits and Sponsorship page for more information about opportunities to exhibit and/or sponsor USCHA.

USCHA’s goal is to build leaders to address the challenges of HIV/AIDS in our communities and ultimately end the epidemic. We look forward to seeing you in New Orleans!

Funding for this conference was made possible in part by a grant from the National Institute of Allergy and Infectious Diseases.

Skip to content